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How did the study come about?  
The Guangzhou Biobank Cohort Study (GCBS), initiated by TH Lam (Hong Kong), CQ 
Jiang (Guangzhou) and KK Cheng (Birmingham), has been in part modelled on the Kadoorie 
Study of Chronic Disease in China (KSCDC)1 and the UK Biobank.2 Initial seed funding 
came from the Universities of Hong Kong and Birmingham, Guangzhou 12th Hospital 
(Guangzhou Occupational Disease Prevention & Treatment Centre), Guangzhou Public 
Health Bureau and Guangzhou Science and Technology Bureau. The Clinical Trials Service 
Unit at Oxford University has provided technical advice, especially in the planning and 
setting up of the project. 
 
Whereas the KSCDC recruits adults aged 35 to 74 years nationwide from five rural counties 
and five urban districts, the Guangzhou Biobank Cohort Study focuses on older people aged 
at least 50 years in a mega-city of approximately 10 million. Of these, 6.4 million are 
permanent residents with locally registered households and the remainder are mostly 
migrants from other parts of the country. Guangzhou, the provincial capital of Guangdong 
province in southern China, is one of the most economically developed regions of China 
(figure 1). Uniquely, the lifetime experience of older urban residents in Guangzhou has 
straddled two macro-environments. Their parents were born into a pre-industrial environment, 
where living standards had been essentially unchanged for millennia3;4 and where male 
heights (an anthropometric marker of living standards) were similar to those in France at their 
pre-industrial nadir.5-10 These circumstances largely continued until after the establishment of 
the People’s Republic of China (PRC) in 1949, although there were some isolated pockets of 
transient, haphazard economic growth along the eastern seaboard and around the treaty ports 
of Shanghai and to a lesser extent Guangzhou during the first half of the 20th century.11;12 
However, with the more inclusive route to economic development taken by the PRC, and in 
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recent decades following the establishment of the special economic zones close to Hong 
Kong in 1978, Guangzhou has been transformed and its residents’ lives with it. Inevitably, 
this very rapid economic progress has been neither smooth nor comprehensive. There have 
been periods of significant hardships, such as during the Japanese occupation in the 1940s, 
the Great Leap Forward in the late 1950s and the Cultural Revolution in the 1960s.13 There 
are also inequalities, and one specifically relevant to this study is the current difficulty of 
access to medical care after the large-scale privatisation of health care facilities since the 
1980s.14 Nevertheless, despite rapid economic transformation, traditional aspects of Chinese 
culture and social norms have been retained, such as more communitarian values and a 
Confucian respect for authority, and specific dietary and lifestyle habits, such as low use of 
alcohol and low female smoking rates.15  
 
In this setting, where the social and historical context can be clearly identified and which has 
a homogeneous population who share a Cantonese heritage with a common dialect, culture 
and cuisine, our main objective is to examine prospectively the determinants of health in a 
population in social transition over the life course. The older residents of Guangzhou provide 
a unique opportunity to gain an early insight into the effects of the epidemiological transition, 
where our findings will be relevant to other parts of China transitioning later or at a slower 
rate, such as the inland industrial cities or the rural areas in the KSCDC, and also to other 
parts of the world currently undergoing rapid economic development.  
 
What does it cover? 
We plan to examine genetic, lifestyle, occupational and environmental factors and life course 
causes of the common chronic diseases, which are emerging with economic development. In 
doing so we would take advantage of natural socio-economic experiments provided by 
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macro-environmental exposures unique to this cohort, some of which are outlined in the 
previous section. The geo-ethnic homogeneity of our cohort helps to reduce the risk of 
population stratification in nested case control studies on genetic association. In addition we 
intend to leverage the concept of Mendelian randomisation16 provided by the distribution of 
common genetic polymorphisms in this population. For example, like other East Asian ethnic 
groups, Chinese have a relatively high frequency of ALDH2*2 alleles17 which slows 
metabolism of potentially carcinogenic acetaldehyde, the first metabolite of alcohol.18 People 
with these alleles have a toxic reaction, including hot flushing, increased heart rate and 
nausea on use of alcohol,18 and the very limited evidence available suggests they may be at a 
greater risk of cancer from acetaldehyde exposure.19;20 Genetic data from this cohort and the 
large proportion of never-drinkers will provide an opportunity to examine whether the 
observed protective effects of moderate alcohol use against cancer mortality in these 
populations21-24 may be the artifactual results of genetic differences between users and non-
users of alcohol. Similarly, the relatively high levels of chronic obstructive pulmonary 
disease (COPD) in women,25 despite low female smoking rates provides an opportunity to 
investigate the aetiology of COPD, in the absence of confounding by smoking.  
 
The very recent history of the epidemiological transition in this cohort potentially provides a 
unique window into some of the unexplained period effects in the epidemics of chronic 
diseases associated with economic development (obesity, ischaemic heart disease (IHD), 
diabetes, hypertension and some cancers), which may yield aetiological clues to their 
environmental determinants. For example, the social patterning of IHD, hypertension and 
obesity appear to vary with epidemic stage;26-28 male disadvantage in IHD risk appears to 
increase with economic development,29;30 whilst a female disadvantage in obesity fades.31 
Specifically, we intend to test whether empirically-driven hypotheses mainly developed in 
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response to observations in economically developed western societies apply in a population 
with a very different history, at a different epidemiological stage, without universal access to 
health care, and potentially with a social patterning of disease more consistent with the early 
stages of the epidemiological transition. Many of these analyses require prospective events to 
accumulate and thus are medium to longer-term aims. Our shorter term objectives are to 
demonstrate the validity of GBCS by confirming the usual expected relationships between 
biological variables in the baseline data; to exploit this study as a retrospective historical 
cohort for the examination of the impact of occupational and lifetime environmental factors 
on baseline physical and mental health, while paying special attention to the possibility that 
people with certain combinations of characteristics may have been excluded from the study 
through differential survivorship, access or otherwise restricted from participation in the 
study; and to verify our hypothesis that the relation between socio-economic variables and 
cardiovascular risk may be more typical of a society at an earlier stage of the epidemiological 
transition.  Clearly a final principal advantage of a large cohort study such as GBCS is the 
open-ended nature of enquiry made possible by the prospective collection of a wide range of 
epidemiologic data and biomaterials thus allowing subsequent prosecution to serve the 
broadest spectrum of research aims, in the tradition of the Framingham,32 Nurses Health33;34 
and British Doctors35;36 cohorts.   
 
Who is in the sample? 
In developed countries, patient registration lists with defined primary care providers are often 
used as sampling frames for studies similar to the present one. In China, the infrastructure to 
facilitate such studies is not available, so a community social and welfare association 
“Guangzhou Zunlao Kangle Xiehui” or “The Guangzhou Health and Happiness Association 
for the Respectable Elders” (GHHARE) aligned with the municipal government, was chosen 
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as a sampling frame. This is a large unofficial organisation with branches throughout 
Guangzhou and membership open to anyone 50 years of age or older for a nominal, monthly 
fee of 4 yuan (1 USD = 8 yuan). Figure 2 shows the sample selection strategy. Figure 3 
shows the overall study plan. Subjects are included if they are permanent Guangzhou 
residents capable of consenting and have agreed to participate, ambulatory, and not receiving 
treatment modalities which if omitted may result in immediate life threatening risk, such as 
chemotherapy or radiotherapy for cancer, or dialysis for renal failure.  The study has ethics 
approval from the Guangzhou Medical Ethics Committee of the Chinese Medical Association, 
Guangzhou, China. 
 
How often will the subjects be followed-up and what is the rate of loss likely to be? 
All subjects will be followed up indefinitely for health services use and cause-specific 
mortality. Currently, health services use and mortality is being tracked continuously through 
GHHARE and cross checked with death records from the Guangzhou Public Health Bureau. 
To ensure completeness and to correct for regression dilution of long-term usual levels of 
certain risks, subjects will be re-contacted every 3-5 years, for interview, examination and 
retrieval of additional information from patient-held discharge summaries issued routinely by 
hospitals, as most health care is fee-for-service and record keeping is an individual 
responsibility. Where possible, morbidity data will be verified against hospital records.  Some 
subjects with specific diseases, such as diabetes and COPD, will also be selected for more 
intensive follow-up and monitoring of the disease progress and development of complications. 
 
A pilot follow-up study 18 months after initial recruitment of the first 1,100 subjects achieved 
re-attendance of 72.2% and telephone interview with a further 22.4%. Information on the 
remaining subjects was sought from family members, close friends and GHHARE, after 
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which only 0.4% remained uncontacted. As a validity check, mortality rates in GBCS will be 
compared with age, sex and cause specific rates in Guangzhou overall.  
 
What has been measured? 
To maximise participation, safety and standardisation, after an overnight fast, all subjects 
come to a newly designed centre at the Guangzhou 12th Hospital, where full time trained 
nurses and technicians carry out examinations and interviews. After the taking of fasting 
bloods, the subjects are given free breakfast, and then circulate through pre-set stations for 
interviews, and for the rest of the physical examination covering measurement of blood 
pressure, anthropometric indices, 12-lead electrocardiography, pulmonary function testing, 
and chest radiograph (Table 1). Fasting blood samples are drawn using a vacutainer tube. 
Lipids, glucose, markers of liver, renal and cardiac function, rheumatoid factor, and high 
sensitivity C-reactive protein are determined automatically in the hospital laboratory. A 
complete blood count is performed. Aliquots of plasma are stored at -80oC, as well as two 
aliquots of bar-coded plasma in liquid nitrogen. White cells extracted using Ficoll-Paque 
extraction are stored in two bar-coded tubes in liquid nitrogen for subsequent immortalisation. 
Urinary cotinine levels are measured as an index of smoking intensity or second hand smoke 
exposure, and to validate the smoking questionnaire.37 Weight, standing height, sitting height, 
waist circumference and hip circumference are measured with light indoor clothing and 
without shoes. Using a face-to-face interview in the appropriate regional dialect, detailed 
information is entered directly by the interviewer onto a computer based standardised 
structured questionnaire, including occupational exposures, socio-economic status, family 
and personal disease histories (in layman terms, as appropriate), cognitive function, smoking 
history, alcohol use, detailed diet (semi-quantitative food frequency)38 and physical activity 
(International Physical Activity Questionnaire short-form) (Table 2).  
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We assessed the reproducibility of the questionnaire responses in 200 subjects from phase 1 
re-interviewed after one month. Examples of the kappa values for a range of categorical 
variables include: smoking (0.96 and 0.88 for the two questions on smoking status), drinking 
(0.60), physical activity (0.58), education (0.90), occupation (0.80), household income (0.60), 
and use of contraceptive pills (0.67), and the intraclass correlation coefficient for continuous 
variables for example are: age at menarche (0.92) and age at first pregnancy (0.50). These 
findings support the reproducibility of the study data collected. The detailed food frequency 
data and self-reports of physical activity will be validated in a subset of subjects at different 
times of the year.  
 
What has it found?  
Following the initial pilot, recruitment of subjects in the first phase took place during 
September 2003 to November 2004, when 10,413 subjects were examined. The sample mean 
age was 64 years, ranging from 50 to 93 years, with 70.6% women. Most of the subjects were 
married and the most common longest held occupation was as a factory worker for 49.5% 
and 37.9% of females and males, respectively. A higher proportion of men than women were 
ever smokers or ever-users of alcohol (57.8 and 71.9% in men and 5.3 and 36.6% in women). 
More women (51.1%) than men (22.5%) were centrally obese (waist circumference ≥90cm 
for men, or ≥80cm for women), although there was less difference in general obesity (body 
mass index ≥ 25 kg/m2), the prevalence of which was 35.5% of women and 31.1% of men.  
 
As per our stated short-term objectives, we have confirmed that internal relationships at 
baseline between biological risk factors are similar to results previously demonstrated 
elsewhere. For example, increasing glycaemia, even in the normal range, is associated with 
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increasing prevalence of vascular risk factors39 (Figure 4), and snoring is associated with a 
history of vascular disease.40 Investigation of inter-relationships between inflammatory 
markers and vascular risk factors is ongoing. Taking a life course perspective, increased 
parity was found associated with increased risk of the metabolic syndrome in women but 
number of children was not associated with such risk in men,41 suggesting a specific 
biological effect of pregnancy rather than a general effect of child rearing (figure 5). Turning 
to setting GBCS within its historical period and epidemiological time, there are different 
associations between socio-economic status and disease from those often seen42, for example 
diabetes was unrelated to socio-economic status (as determined by educational level and 
longest held occupation) in women, and possibly associated with higher socio-economic 
status in men (figure 6).  
 
What are the main strengths and weaknesses? 
This large, carefully designed cohort study with detailed baseline characterisation of the 
subjects has been conceived to investigate a wide range of chronic diseases in a southern 
Chinese population that has undergone rapid economic transition. GBCS will provide 
important evidence in the determination of risk factors of chronic disease that emerge with 
economic development.  
 
Study participants are members of a well-organised association, permanent residents of 
Guangzhou recruited at one centre closely connected with a well-equipped general hospital, 
so recruitment is efficient and follow up is facilitated. Using the elderly association is a 
practicable way to recruit and track large numbers of subjects at low cost without relying on 
networks of social control such as street and village committees, and the response rate is high. 
Standardised and mostly automated collection of detailed baseline and follow up information 
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in a single centre by a small well-trained team with the same high quality, calibrated 
equipment maximise reliability, validity and data access. Recruitment of subjects steadily 
throughout the year, coupled with post hoc adjustment as appropriate, removes the possibility 
of biases caused by potentially large seasonal variation in baseline factors, such as dietary 
pattern, systolic blood pressure43 or C-reactive protein.44 
 
The older ages of cohort participants means that sufficient numbers of incident outcome 
events can be expected within a relatively short time period. Results from the prospective and 
nested case-control studies of relevance to the rest of China transitioning at a slower rate can 
be expected within a short time frame. 
 
The collection of fasting blood samples and live white cells for later immortalisation are 
unique among large cohort studies in China. Tests conducted after 3 months of storage found 
the rate of viability of the white cells was more than 95%. Cell cultures can be used to 
provide unlimited genomic DNA and are an invaluable source for cytogenetic studies and 
testing for drug treatment, proteins for proteomic studies, and mRNA. Additional storage of 
blood at –80oC allows DNA extraction without retrieving the live white cells. 
 
Several challenges bear mention.  Our subjects are unlikely to be completely representative of 
the older population of Guangzhou although they are an unselected sample of GHHARE. 
Specifically women are over-represented, which we are urgently addressing in the ongoing 
rounds (phases 2 and 3) of recruitment. Nevertheless within sex and age-group, the phase 1 
subjects had fairly similar levels of diabetes and hypertension to nationally representative 
samples of urban Chinese45;46 (Figure 7). Notwithstanding these similarities and the lack of 
easy access to health care, we cannot rule out the possibility of “healthy volunteer bias” 
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among people who have chosen to join GHHARE, and by extension the potential for a type 
of “reverse Berkson’s bias*” particularly in subsequent nested case-control sub-studies where 
the prevalence of exposure to a health risk would expectedly be artifactually lower in our 
sample than the general population thus possibly leading to an overestimation of its effect 
size. Specifically, the exclusion criteria as stated might result in a lower prevalence of general 
ill health, cancer and renal failure. As such, GBCS is unsuited to estimate disease prevalences, 
and in common with many non-representative cohort studies the internal validity of 
relationships is open to bias, if for example subjects with specifically different relationships 
from those observed are missing. We are planning to investigate, through the use of 
simulations, what effects such missing data could have. Additionally, in common with all 
cohorts in developing countries, our subjects are with age increasingly strongly selected 
survivors. In particular, our subjects survived childhood infections in a pre-antibiotic 
environment, lived through periodic social turmoil up until the 1970s, and did not move to 
Hong Kong where until the 1980s immigration from Guangdong province had been 
commonplace. If survivorship were an issue, we would expect different relationships in the 
older compared with the younger subjects, which we will check for routinely. The present 
sample size is not sufficient for studying diseases of lower incidence, such as specific types 
of cancer. The amount of plasma stored is limited (two cryovials of 1.8ml each per subject), 
as we can only collect about 18ml of blood, some of which is used for baseline biochemical 
assays.   
 
Where can I find out more? 
                                                          
* Whereas Berkson’s bias as originally conceived points to the fact that individuals with two diseases may seek 
treatment for either one, thus increasing the probability that they will present to the health care system and be 
diagnosed as having the other condition. Thus the prevalence of a second condition that is estimated from a 
treated (for the first condition) sample is likely to over-represent both the second condition and the co-
occurrence of the two conditions in the general population. By reverse Berkson’s bias, therefore, we mean that 
the prevalence estimates of a second condition from our healthy volunteer sample are likely to underestimate the 
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We aim to complete recruitment of the final target of 30,000 subjects by the end of 2007. 
Although we have no immediate plans to make the data freely available in the public domain, 
specific proposals for collaboration are welcomed.  We are developing a website for the study 
(www.hku.hk/gbcs) which should be available by December 2006 and further details may be 
obtained from the site or from commed@hkucc.hku.hk. 
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true burden of disease in the underlying population. 
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Table 1: Summary of clinical measures collected at baseline in the GBCS 
Variables Number of 
measure-
ments 
Equipment used Method 
Standing height Once  
Sitting height Once 
Manufactured equipment 
 
Hip circumference Once Around the maximal girth of the hips 
Waist circumference  Once 
Standard tape measure 
Horizontally around the smallest circumference between  
ribs and iliac crest, or at the navel, if no natural waistline 
Weight Once RGZ-120-RT, Wuxi weighing 
apparatus factory(无锡市衡器厂) 
 
Resting blood pressure Three Omron 705CP Seated blood pressure, one minute apart, after a 3-minute 
rest. 
Forced expiratory volume in 1 sec (FEV1) 
Forced vital capacity (FVC) 
Best three 
of up to 
eight 
COSMED microQuark As per American Thoracic Society / European Respiratory 
Society (ATS/ERS) task force recommendations, but 
without reversibility testing 
12-lead electrocardiography Once Marquette CE0366  
Chest X-ray Once Toshiba 500mA  
Fasting plasma glucose Once  
Lipid profilea Once  
Markers of liverb, renalc and cardiacd function  Once  
Rheumatoid factor Once  
C-reactive protein Once 
Shimadzu CL-8000  
Clinical Chemistry Analyzer  
 
 
Complete blood counte Once SYSMAX K-21  
Urinary cotinine Once Agilent 6890 series GC System, 
Agilent 5973 Network Mass 
Selective Detector 
 
a total, LDL-, and HDL-cholesterol, triglycerides, apolipoprotein A1 and B 
b alanine aminotransferase, aspartate transaminase 
c total protein, albumin, globulin, total bilirubin, urea, creatinine, uric acid, phosphate, total calcium, magnesium  
d creatine kinase, lactate dehydrogenase, hydroxybutyrate dehydrogenase 
e white (and subtypes) and red blood cell counts, haemoglobin levels, and platelet counts  
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Table 2: Summary of questionnaire data collected at baseline in the GBCS 
Exposure category Variable / exposure 
Demographics and socio-
economics  
Housing type 
Household size 
Occupation 
Income 
Education 
Health insurance coverage 
Personal health behaviour Smoking 
Alcohol 
Tea 
Spicy food 
Afternoon nap 
Physical activity (at work and leisure) 
Diet (300-item food frequency questionnaire)  
Environment Occupational exposures 
Cooking and heating fuels 
Passive smoking exposure 
Family history Family history of coronary heart disease, diabetes, cancers, other 
chronic diseases 
Parental age, age of death and cause of death 
Specific health questions/ 
disability/impairment 
Rose angina screening questionnaire 
MRC respiratory health questionnaire 
Self-reported general health  
Arthritis screening / activities of daily living (ADL) 
Dementia screening (delayed word recall test) 
Eyesight 
Hearing 
Dental health 
Past medical history Diagnosed medical conditions (specifically itemised) 
Use of health services 
Use of Chinese medicines 
Western and other medication use 
Reproductive history Age of menarche 
Parity and breastfeeding history  
Menopause status and associated timing 
Contraceptive history 
History of hormone-replacement therapy use 
Hysterectomy or other gynaecological interventions 
Psychological status Psychological morbidity scales / stress 
Anger / hostility  
Optimism 
Social isolation 
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Figure 1: Location of major urban areas in China, with populations of more than about 10 
million  
 
 
 
 
Figure 2: Participant recruitment  
Population of  Guangzhou city ~10 million, 
permanent residents  6.4 million
10,850  randomly selected for phase 1
- eligible  and  consented, 10413
men  3064
women 7349 
- not eligible or did not consent, 437
men 350
women 87    
Aged 50 years or older, 1.4 million 
Members of the GHHARE and permanent 
residents, ~95,000  
Follow-up at 4 yearly intervals, till death, 
- expected completion 9372
- loss and withdrawal 1041* 
11,000  randomly selected for phase 2
- 95% eligibility and consent targeted  
11,000  randomly selected for phase 3
- 95% eligibility and consent targeted  
Follow-up at 4 yearly intervals, till death, 
- expected completion ~95%*
Follow-up at 4 yearly intervals, till death, 
- expected completion ~95%* 
* Lost to follow-up may be tracked  in local mortality registers
Continual monitoring of health services use, unless specifically withdraw (likely to be less than 1%)
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Figure 3: Study plan 
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022
Planning & piloting 
Phase 1 
baseline
Phase 3 
baseline
Phase 2 
baseline
Pilot 
follow-up Phase 1 follow-up
Continual monitoring of morbidity and mortality 
Short-term objectives
• establish internal consistency of study 
• use baseline data as historical cohort
• set cohort within its epidemiological time
• examine potential causes of bias 
Medium term objectives
• prospective studies of common 
diseases, such as diabetes
• genetic studies
Long term objectives
• prospective studies of less 
common diseases
• genetic studies
Phase 2 
follow-up
Phase 3 
follow-up
Intensive follow-up of sub-cohorts
 
 
 
Figure 4: Relationship between increasing fasting plasma glucose in the normal range and 
selected cardiovascular risk factors (LOWESS plot) 
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Figure 5: Relationship between number of children and prevalence of the metabolic 
syndrome (MS) in women and men, using the International Diabetes Federation definition47, 
adjusted for age, socio-economic status, use of alcohol, smoking and physical activity. 
Figure 6: Relationship between prevalence of diabetes* and educational level and longest 
held occupation by sex, adjusted for age, smoking, use of alcohol and physical activity 
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Figure 7: Prevalence of Diabetes* and Hypertension† in GBCS compared with a nationally 
representative urban sample45;46, with 95% confidence intervals 
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